IP Library Granted Patent US 11,806,300
Granted Patent B2
US 11,806,300 · App. 18/084,629 · Granted Nov 7, 2023

Method and system of mechanical nerve stimulation for pain relief

Inventors: Meredith McGee (Cary, NC); Nathan Crosby (Cleveland, OH); John Chae (Strongsville, OH); Joseph W. Boggs (Chapel Hill, NC)
Assignee: SPR Therapeutics, Inc.
A61H23/006A61H23/004A61H39/08A61H2203/03
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,806,300
App. No.
18/084,629
Granted
Nov 7, 2023
Kind
B2
Abstract

A system and method of using a lead introduced to a subject proximate to a region of pain is contemplated to deliver pain relief without the need for multiple needle insertions or electrical stimulation. The three-dimensional lead may include spring-like characteristics and/or coils to translate mechanical energy into the therapy.

Claims (26)

1. A method comprising:

percutaneously implanting a flexible, open-coiled helical structure in a tissue of a body;

allowing mechanical connection of the helical structure to a neural receptor in the tissue of the body; and

after mechanical connection of the helical structure, mechanically generating an action potential in at least one of Type Ia and Ib target afferent nerve fibers while avoiding generation of action potentials in non-target Type III and IV nerve fibers, wherein the at least one of Type Ia and Ib target afferent nerve fibers are located outside a central nervous system of the body, and wherein the mechanical generation of the action potential occurs through the helical structure transferring energy from movement of the helical structure relative to the tissue and without electrical stimulation to reduce a perception of pain.

2. A method according to claim 1 , wherein the at least one of Type Ia and Ib target afferent nerve fibers are located between the neural receptor and the central nervous system.

3. A method according to claim 1 , wherein the at least one of Type Ia and Ib target afferent nerve fibers innervate the neural receptor.

4. A method according to claim 1 , wherein the neural receptor is a proprioceptor.

5. A method according to claim 1 , wherein the at least one of Type Ia and Ib target afferent nerve fibers are in neural communication with the neural receptor and are activated at a location that is between the neural receptor and the central nervous system.

6. A method according to claim 5 , wherein the neural receptor is a proprioceptor.

7. A method according to claim 1 , wherein the non-target nerve fibers include efferent nerve fibers.

8. A method according to claim 1 , wherein the at least one of Type Ia and Ib target afferent nerve fibers are located outside the neural receptor.

9. A method for reducing a perception of pain comprising:

percutaneously implanting an open-coiled helical structure in a tissue of a body;

applying mechanical stimulation by transferring energy from movement of the open-coiled helical structure inserted, wherein fibrotic ingrowth or encapsulation of the open-coiled helical structure to the tissue mechanically connects the open-coiled helical structure to tissue connected to neural receptors of target Type I afferent nerve fibers to generate an action potential in the target Type I afferent nerve fibers while avoiding delivering mechanical stimulation that generate action potentials in non-target Type III and Type IV afferent nerve fibers, and wherein the mechanical stimulation occurs without electrical stimulation and muscle contraction caused by the electrical stimulation.

10. A method according to claim 9 , wherein the target Type I afferent nerve fibers are located neurologically between and outside the neural receptors and a central nervous system.

11. A method according to claim 9 , wherein the target Type I afferent nerve fibers comprise either of Type 1a and Type 1b nerve fibers.

12. A method according to claim 9 , wherein the non-target nerve fibers comprise efferent nerve fibers.

13. A method according to claim 9 , wherein the mechanical stimulation comprises stretching of the tissues and activation of nerve endings or the neural receptors connected to afferent fibers proximate to the tissue.

14. A method according to claim 13 , wherein the stretching is above a threshold for generation of action potentials in target Type 1 fibers while also being below a threshold for generation of action potentials in non-target Type III and Type IV fibers.

15. A method of pain relief comprising:

positioning a stimulation device having an open coil, helical structure in human tissue proximate to neural receptors of target Type I afferent nerve fibers;

mechanically connecting the open coil, helical structure to tissue connected to a neural receptor;

transferring energy from movement of the stimulation device relative to the human tissue so as to generate an action potential in the target Type I afferent nerve fibers; and

wherein the generation of action potential does not require electrical stimulation and does not generate action potentials in non-target Type III and/or Type IV afferent nerve fibers.

16. The method of claim 15 , wherein the mechanical connection of the stimulation device to the tissue comprises allowing fibrotic ingrowth and/or encapsulation of the open coil, helical structure with the human tissue.

17. The method of claim 16 wherein a proximal section of the open coil, helical structure is positioned outside of the human tissue and is covered by a bandage.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2023
From: MCGEE, MEREDITH; CROSBY, NATHAN; CHAE, JOHN; BOGGS, JOSEPH W.
To: SPR THERAPEUTICS, INC.
Reel/Frame 065043/0109 →